118 related articles for article (PubMed ID: 31902296)
1. Computer-aided screening for suppressor of variegation 4-20 homolog 1 inhibitors and their preliminary activity validation in human osteosarcoma.
Zheng R; Liang D; Jiang N; Zhou J; Long X; Wang X; Wu M; Wu C; Bao J
J Biomol Struct Dyn; 2021 Feb; 39(2):526-537. PubMed ID: 31902296
[TBL] [Abstract][Full Text] [Related]
2. Catalytic and non-catalytic mechanisms of histone H4 lysine 20 methyltransferase SUV420H1.
Abini-Agbomson S; Gretarsson K; Shih RM; Hsieh L; Lou T; De Ioannes P; Vasilyev N; Lee R; Wang M; Simon MD; Armache JP; Nudler E; Narlikar G; Liu S; Lu C; Armache KJ
Mol Cell; 2023 Aug; 83(16):2872-2883.e7. PubMed ID: 37595555
[TBL] [Abstract][Full Text] [Related]
3. Somatic Cancer Mutations in the SUV420H1 Protein Lysine Methyltransferase Modulate Its Catalytic Activity.
Bröhm A; Elsawy H; Rathert P; Kudithipudi S; Schoch T; Schuhmacher MK; Weirich S; Jeltsch A
J Mol Biol; 2019 Aug; 431(17):3068-3080. PubMed ID: 31255706
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures of the human histone H4K20 methyltransferases SUV420H1 and SUV420H2.
Wu H; Siarheyeva A; Zeng H; Lam R; Dong A; Wu XH; Li Y; Schapira M; Vedadi M; Min J
FEBS Lett; 2013 Nov; 587(23):3859-68. PubMed ID: 24396869
[TBL] [Abstract][Full Text] [Related]
5. Comparative analyses of SUV420H1 isoforms and SUV420H2 reveal differences in their cellular localization and effects on myogenic differentiation.
Tsang LW; Hu N; Underhill DA
PLoS One; 2010 Dec; 5(12):e14447. PubMed ID: 21206904
[TBL] [Abstract][Full Text] [Related]
6. Catalytic and non-catalytic mechanisms of histone H4 lysine 20 methyltransferase SUV420H1.
Abini-Agbomson S; Gretarsson K; Shih RM; Hsieh L; Lou T; De Ioannes P; Vasilyev N; Lee R; Wang M; Simon M; Armache JP; Nudler E; Narlikar G; Liu S; Lu C; Armache KJ
bioRxiv; 2023 Mar; ():. PubMed ID: 36993485
[TBL] [Abstract][Full Text] [Related]
7. Histone-modifier gene expression profiles are associated with pathological and clinical outcomes in human breast cancer.
Patani N; Jiang WG; Newbold RF; Mokbel K
Anticancer Res; 2011 Dec; 31(12):4115-25. PubMed ID: 22199269
[TBL] [Abstract][Full Text] [Related]
8. Histone H3 lysine 9 and H4 lysine 20 trimethylation and the expression of Suv4-20h2 and Suv-39h1 histone methyltransferases in hepatocarcinogenesis induced by methyl deficiency in rats.
Pogribny IP; Ross SA; Tryndyak VP; Pogribna M; Poirier LA; Karpinets TV
Carcinogenesis; 2006 Jun; 27(6):1180-6. PubMed ID: 16497704
[TBL] [Abstract][Full Text] [Related]
9. Impact of Histone Lysine Methyltransferase SUV4-20H2 on Cancer Onset and Progression with Therapeutic Potential.
Papadaki S; Piperi C
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473745
[TBL] [Abstract][Full Text] [Related]
10. Targeting Histone Methylation in Cancer.
McCabe MT; Mohammad HP; Barbash O; Kruger RG
Cancer J; 2017; 23(5):292-301. PubMed ID: 28926430
[TBL] [Abstract][Full Text] [Related]
11. IVMBIX-01294, an inhibitor of the histone methyltransferase EHMT2, disrupts histone H3 lysine 9 (H3K9) dimethylation in the cleavage-stage porcine embryo.
Park KE; Johnson CM; Cabot RA
Reprod Fertil Dev; 2012; 24(6):813-21. PubMed ID: 22781932
[TBL] [Abstract][Full Text] [Related]
12. Cross-species Analyses Unravel the Complexity of H3K27me3 and H4K20me3 in the Context of Neural Stem Progenitor Cells.
Rhodes CT; Sandstrom RS; Huang SA; Wang Y; Schotta G; Berger MS; Lin CA
Neuroepigenetics; 2016 Jun; 6():10-25. PubMed ID: 27429906
[TBL] [Abstract][Full Text] [Related]
13. [Advances in histone methyltransferases and histone demethylases].
Wang X; Zhu WG
Ai Zheng; 2008 Oct; 27(10):1018-25. PubMed ID: 18851779
[TBL] [Abstract][Full Text] [Related]
14. Loss of DNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression of DNA methyltransferase 1, Suv4-20h2 histone methyltransferase and methyl-binding proteins.
Tryndyak VP; Kovalchuk O; Pogribny IP
Cancer Biol Ther; 2006 Jan; 5(1):65-70. PubMed ID: 16322686
[TBL] [Abstract][Full Text] [Related]
15. Insights into the epigenetic mechanisms involving histone lysine methylation and demethylation in ischemia induced damage and repair has therapeutic implication.
Chakravarty S; Jhelum P; Bhat UA; Rajan WD; Maitra S; Pathak SS; Patel AB; Kumar A
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):152-164. PubMed ID: 27664837
[TBL] [Abstract][Full Text] [Related]
16. [The roles of histone lysine methylation in epigenetic regulation].
Du TT; Huang QH
Yi Chuan; 2007 Apr; 29(4):387-92. PubMed ID: 17548299
[TBL] [Abstract][Full Text] [Related]
17. Writing, erasing and reading histone lysine methylations.
Hyun K; Jeon J; Park K; Kim J
Exp Mol Med; 2017 Apr; 49(4):e324. PubMed ID: 28450737
[TBL] [Abstract][Full Text] [Related]
18. Elevated H3K27me3 levels sensitize osteosarcoma to cisplatin.
He C; Sun J; Liu C; Jiang Y; Hao Y
Clin Epigenetics; 2019 Jan; 11(1):8. PubMed ID: 30651137
[TBL] [Abstract][Full Text] [Related]
19. Histone methyltransferase SMYD2: ubiquitous regulator of disease.
Yi X; Jiang XJ; Fang ZM
Clin Epigenetics; 2019 Aug; 11(1):112. PubMed ID: 31370883
[TBL] [Abstract][Full Text] [Related]
20. In silico probing and biological evaluation of SETDB1/ESET-targeted novel compounds that reduce tri-methylated histone H3K9 (H3K9me3) level.
Park I; Hwang YJ; Kim T; Viswanath ANI; Londhe AM; Jung SY; Sim KM; Min SJ; Lee JE; Seong J; Kim YK; No KT; Ryu H; Pae AN
J Comput Aided Mol Des; 2017 Oct; 31(10):877-889. PubMed ID: 28879500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
